Talk:ABCC2: Difference between revisions
Jump to navigation
Jump to search
→Abstract: new section |
No edit summary |
||
| Line 1: | Line 1: | ||
== Abstract == | == Abstract == | ||
Castillo VF, Yacoub JM, Cornacchia K, Patel S, Mimosa M, Zakhary A, van der Kwast T, Trpkov K, Saleeb R, 2026, "Papillary renal cell carcinoma with ABCC2 brush border immunoreactivity confers resistance to cabozantinib, highlighting the therapeutic potential of ABCC2 inhibition", Canadian Kidney Cancer Forum. | |||
Latest revision as of 01:16, 19 May 2026
Abstract
Castillo VF, Yacoub JM, Cornacchia K, Patel S, Mimosa M, Zakhary A, van der Kwast T, Trpkov K, Saleeb R, 2026, "Papillary renal cell carcinoma with ABCC2 brush border immunoreactivity confers resistance to cabozantinib, highlighting the therapeutic potential of ABCC2 inhibition", Canadian Kidney Cancer Forum.